1 Market Overview of Covid-19 Vaccine |
|
1.1 Covid-19 Vaccine Market Overview |
|
| 1.1.1 Covid-19 Vaccine Product Scope | |
| 1.1.2 Market Status and Outlook | |
1.2 Global Covid-19 Vaccine Market Size Overview by Region 2015 VS 2020 VS 2026 |
|
1.3 Global Covid-19 Vaccine Market Size by Region (2015-2026) |
|
1.4 Global Covid-19 Vaccine Historic Market Size by Region (2015-2020) |
|
1.5 Global Covid-19 Vaccine Market Size Forecast by Region (2021-2026) |
|
1.6 Key Regions Covid-19 Vaccine Market Size YoY Growth (2015-2026) |
|
| 1.6.1 North America Covid-19 Vaccine Market Size YoY Growth (2015-2026) | |
| 1.6.2 Europe Covid-19 Vaccine Market Size YoY Growth (2015-2026) | |
| 1.6.3 China Covid-19 Vaccine Market Size YoY Growth (2015-2026) | |
| 1.6.4 Rest of Asia Pacific Covid-19 Vaccine Market Size YoY Growth (2015-2026) | |
| 1.6.5 Latin America Covid-19 Vaccine Market Size YoY Growth (2015-2026) | |
| 1.6.6 Middle East & Africa Covid-19 Vaccine Market Size YoY Growth (2015-2026) | |
2 Covid-19 Vaccine Market Overview by Platform |
|
2.1 Global Covid-19 Vaccine Market Size by Platform: 2015 VS 2020 VS 2026 |
|
2.2 Global Covid-19 Vaccine Historic Market Size by Platform (2015-2020) |
|
2.3 Global Covid-19 Vaccine Forecasted Market Size by Platform (2021-2026) |
|
2.4 DNA |
|
2.5 Live Attenuated Virus |
|
2.6 NonReplicating Viral Vecto |
|
2.7 Protein Subunit |
|
2.8 RNA |
|
3 Covid-19 Vaccine Market Overview by Platform |
|
3.1 Global Covid-19 Vaccine Market Size by Purpose: 2015 VS 2020 VS 2026 |
|
3.2 Global Covid-19 Vaccine Historic Market Size by Purpose (2015-2020) |
|
3.3 Global Covid-19 Vaccine Forecasted Market Size by Purpose (2021-2026) |
|
3.4 Treatment |
|
3.5 Prevention |
|
4 Global Covid-19 Vaccine Competition Analysis by Players |
|
4.1 Global Covid-19 Vaccine Market Size (Million US$) by Players (2015-2020) |
|
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Vaccine as of 2019) |
|
4.3 Date of Key Manufacturers Enter into Covid-19 Vaccine Market |
|
4.4 Global Top Players Covid-19 Vaccine Headquarters and Area Served |
|
4.5 Key Players Covid-19 Vaccine Product Solution and Service |
|
4.6 Competitive Status |
|
| 4.6.1 Covid-19 Vaccine Market Concentration Rate | |
| 4.6.2 Mergers & Acquisitions, Expansion Plans | |
5 Company (Top Players) Profiles and Key Data |
|
| 全:文：http://www.5269660.cn/6/29/2020-2026-Global-Covid-19-Vaccine-Industry-In-Depth-Research-and-Trends-Forecast-Report.html | |
5.1 Company 1 |
|
| 5.1.1 Company 1 Profile | |
| 5.1.2 Company 1 Main Business and Company's Total Revenue | |
| 5.1.3 Company 1 Products, Services and Solutions | |
| 5.1.4 Company 1 Revenue (US$ Million) (2015-2020) | |
| 5.1.5 Company 1 Recent Developments | |
5.2 Company 2 |
|
| 5.2.1 Company 2 Profile | |
| 5.2.2 Company 2 Main Business and Company's Total Revenue | |
| 5.2.3 Company 2 Products, Services and Solutions | |
| 5.2.4 Company 2 Revenue (US$ Million) (2015-2020) | |
| 5.2.5 Company 2 Recent Developments | |
5.3 Company 3 |
|
| 5.5.1 Company 3 Profile | |
| 5.3.2 Company 3 Main Business and Company's Total Revenue | |
| 5.3.3 Company 3 Products, Services and Solutions | |
| 5.3.4 Company 3 Revenue (US$ Million) (2015-2020) | |
| 5.3.5 Company 4 Recent Developments | |
5.4 Company 4 |
|
| 5.4.1 Company 4 Profile | |
| 5.4.2 Company 4 Main Business and Company's Total Revenue | |
| 5.4.3 Company 4 Products, Services and Solutions | |
| 5.4.4 Company 4 Revenue (US$ Million) (2015-2020) | |
| 5.4.5 Company 4 Recent Developments | |
5.5 Company 5 |
|
| 5.5.1 Company 5 Profile | |
| 5.5.2 Company 5 Main Business and Company's Total Revenue | |
| 5.5.3 Company 5 Products, Services and Solutions | |
| 5.5.4 Company 5 Revenue (US$ Million) (2015-2020) | |
| 5.5.5 Company 5 Recent Developments | |
5.6 Company 6 |
|
| 5.6.1 Company 6 Profile | |
| 5.6.2 Company 6 Main Business and Company's Total Revenue | |
| 5.6.3 Company 6 Products, Services and Solutions | |
| 5.6.4 Company 6 Revenue (US$ Million) (2015-2020) | |
| 5.6.5 Company 6 Recent Developments | |
5.7 Company 7 |
|
| 5.7.1 Company 7 Profile | |
| 5.7.2 Company 7 Main Business and Company's Total Revenue | |
| 5.7.3 Company 7 Products, Services and Solutions | |
| 5.7.4 Company 7 Revenue (US$ Million) (2015-2020) | |
| 5.7.5 Company 7 Recent Developments | |
5.8 Company 8 |
|
| 5.8.1 Company 8 Profile | |
| 5.8.2 Company 8 Main Business and Company's Total Revenue | |
| 5.8.3 Company 8 Products, Services and Solutions | |
| 5.8.4 Company 8 Revenue (US$ Million) (2015-2020) | |
| 5.8.5 Company 8 Recent Developments | |
5.9 Company 9 |
|
| 5.9.1 Company 9 Profile | |
| 5.9.2 Company 9 Main Business and Company's Total Revenue | |
| 5.9.3 Company 9 Products, Services and Solutions | |
| 5.9.4 Company 9 Revenue (US$ Million) (2015-2020) | |
| 5.9.5 Company 9 Recent Developments | |
5.10 Company 10 |
|
| 5.10.1 Company 10 Profile | |
| 5.10.2 CanSino Biologiain Business and Company's Total Revenue | |
| 5.10.3 Company 10 Products, Services and Solutions | |
| 5.10.4 Company 10 Revenue (US$ Million) (2015-2020) | |
| 5.10.5 Company 10 Recent Developments | |
5.11 Company 11 |
|
| 5.11.1 Company 11 Profile | |
| 5.11.2 Company 11 Main Business and Company's Total Revenue | |
| 5.11.3 Company 11 Products, Services and Solutions | |
| 5.11.4 Company 11 Revenue (US$ Million) (2015-2020) | |
| 5.11.5 Company 11 Recent Developments | |
5.12 Company 12 |
|
| 5.12.1 Company 12 Profile | |
| 5.12.2 Company 12 Main Business and Company's Total Revenue | |
| 5.12.3 Company 12 Products, Services and Solutions | |
| 5.12.4 Company 12 Revenue (US$ Million) (2015-2020) | |
| 5.12.5 Company 12 Recent Developments | |
5.13 Company 13 |
|
| 5.13.1 Company 13 Profile | |
| 5.13.2 Company 13 Main Business and Company's Total Revenue | |
| 5.13.3 Company 13 Products, Services and Solutions | |
| 5.13.4 Company 13 Revenue (US$ Million) (2015-2020) | |
| 5.13.5 Company 13 Recent Developments | |
5.14 Company 14 |
|
| 5.14.1 Company 14 Profile | |
| 5.14.2 Company 14 Main Business and Company's Total Revenue | |
| 二零二零年至2026年全球Covid-19疫苗行業深度研究及發展趨勢預測報告 | |
| 5.14.3 Company 14 Products, Services and Solutions | |
| 5.14.4 Company 14 Revenue (US$ Million) (2015-2020) | |
| 5.14.5 Company 14 Recent Developments | |
5.15 Company 15 |
|
| 5.15.1 Company 15 Profile | |
| 5.15.2 Company 15 Main Business and Company's Total Revenue | |
| 5.15.3 Company 15 Products, Services and Solutions | |
| 5.15.4 Company 15 Revenue (US$ Million) (2015-2020) | |
| 5.15.5 Company 15 Recent Developments | |
5.16 Company 16 |
|
| 5.16.1 Company 16 Profile | |
| 5.16.2 Company 16 Main Business and Company's Total Revenue | |
| 5.16.3 Company 16 Products, Services and Solutions | |
| 5.16.4 Company 16 Revenue (US$ Million) (2015-2020) | |
| 5.16.5 Company 16 Recent Developments | |
5.17 Company 17 |
|
| 5.17.1 Company 17 Profile | |
| 5.17.2 Company 17 Main Business and Company's Total Revenue | |
| 5.17.3 Company 17 Products, Services and Solutions | |
| 5.17.4 Company 17 Revenue (US$ Million) (2015-2020) | |
| 5.17.5 Company 17 Recent Developments | |
5.18 Company 18 |
|
| 5.18.1 Company 18 Profile | |
| 5.18.2 Company 18 Main Business and Company's Total Revenue | |
| 5.18.3 Company 18 Products, Services and Solutions | |
| 5.18.4 Company 18 Revenue (US$ Million) (2015-2020) | |
| 5.18.5 Company 18 Recent Developments | |
5.19 Company 19 |
|
| 5.19.1 Company 19 Profile | |
| 5.19.2 Company 19 Main Business and Company's Total Revenue | |
| 5.19.3 Company 19 Products, Services and Solutions | |
| 5.19.4 Company 19 Revenue (US$ Million) (2015-2020) | |
| 5.19.5 Company 19 Recent Developments | |
5.20 Company 3 |
|
| 5.20.1 Company 3 Profile | |
| 5.20.2 Company 3 Main Business and Company's Total Revenue | |
| 5.20.3 Company 3 Products, Services and Solutions | |
| 5.20.4 Company 3 Revenue (US$ Million) (2015-2020) | |
| 5.20.5 Company 3 Recent Developments | |
5.21 Company 21 |
|
| 5.21.1 Company 21 Profile | |
| 5.21.2 Company 21 Main Business and Company's Total Revenue | |
| 5.21.3 Company 21 Products, Services and Solutions | |
| 5.21.4 Company 21 Revenue (US$ Million) (2015-2020) | |
| 5.21.5 Company 21 Recent Developments | |
5.22 Company 22 |
|
| 5.22.1 Company 22 Profile | |
| 5.22.2 Company 22 Main Business and Company's Total Revenue | |
| 5.22.3 Company 22 Products, Services and Solutions | |
| 5.22.4 Company 22 Revenue (US$ Million) (2015-2020) | |
| 5.22.5 Company 22 Recent Developments | |
5.23 Company 23 |
|
| 5.23.1 Company 23 Profile | |
| 5.23.2 Company 23 Main Business and Company's Total Revenue | |
| 5.23.3 Company 23 Products, Services and Solutions | |
| 5.23.4 Company 23 Revenue (US$ Million) (2015-2020) | |
| 5.23.5 Company 23 Recent Developments | |
6 North America Covid-19 Vaccine by Players and by Purpose |
|
6.1 North America Covid-19 Vaccine Market Size and Market Share by Players (2015-2020) |
|
6.2 North America Covid-19 Vaccine Market Size by Purpose (2015-2020) |
|
7 Europe Covid-19 Vaccine by Players and by Purpose |
|
7.1 Europe Covid-19 Vaccine Market Size and Market Share by Players (2015-2020) |
|
7.2 Europe Covid-19 Vaccine Market Size by Purpose (2015-2020) |
|
8 China Covid-19 Vaccine by Players and by Purpose |
|
8.1 China Covid-19 Vaccine Market Size and Market Share by Players (2015-2020) |
|
8.2 China Covid-19 Vaccine Market Size by Purpose (2015-2020) |
|
9 Rest of Asia Pacific Covid-19 Vaccine by Players and by Purpose |
|
9.1 Rest of Asia Pacific Covid-19 Vaccine Market Size and Market Share by Players (2015-2020) |
|
9.2 Rest of Asia Pacific Covid-19 Vaccine Market Size by Purpose (2015-2020) |
|
10 Latin America Covid-19 Vaccine by Players and by Purpose |
|
10.1 Latin America Covid-19 Vaccine Market Size and Market Share by Players (2015-2020) |
|
10.2 Latin America Covid-19 Vaccine Market Size by Purpose (2015-2020) |
|
11 Middle East & Africa Covid-19 Vaccine by Players and by Purpose |
|
11.1 Middle East & Africa Covid-19 Vaccine Market Size and Market Share by Players (2015-2020) |
|
11.2 Middle East & Africa Covid-19 Vaccine Market Size by Purpose (2015-2020) |
|
12 Covid-19 Vaccine Market Dynamics |
|
12.1 Industry Trends |
|
12.2 Market Drivers |
|
12.3 Market Challenges |
|
12.4 Porter's Five Forces Analysis |
|
13 Research Finding /Conclusion |
|
| 二零二零年至2026年全球Covid-19疫苗行業深度研究及發展趨勢預測報告 | |
14 Methodology and Data Source |
|
14.1 Methodology/Research Approach |
|
| 14.1.1 Research Programs/Design | |
| 14.1.2 Market Size Estimation | |
| 14.1.3 Market Breakdown and Data Triangulation | |
14.2 Data Source |
|
| 14.2.1 Secondary Sources | |
| 14.2.2 Primary Sources | |
14.3 Disclaimer |
|
14.4 Author List |
|
| List of Tables | |
| Table 1. Global Market Covid-19 Vaccine Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 | |
| Table 2. Global Covid-19 Vaccine Market Size by Region (2015-2020) (US$ Million) | |
| Table 3. Global Covid-19 Vaccine Market Size Share by Region (2015-2020) | |
| Table 4. Global Covid-19 Vaccine Forecasted Market Size by Region (2021-2026) (US$ Million) | |
| Table 5. Global Covid-19 Vaccine Forecasted Market Size Share by Region (2021-2026) | |
| Table 6. Global Covid-19 Vaccine Market Size (US$ Million) by Platform: 2015 VS 2020 VS 2026 | |
| Table 7. Global Covid-19 Vaccine Market Size by Platform (2015-2020) (US$ Million) | |
| Table 8. Global Covid-19 Vaccine Revenue Market Share by Platform (2015-2020) | |
| Table 9. Global Covid-19 Vaccine Forecasted Market Size by Platform (2021-2026) (US$ Million) | |
| Table 10. Global Covid-19 Vaccine Revenue Market Share by Platform (2021-2026) | |
| Table 11. Global Covid-19 Vaccine Market Size (US$ Million) by Purpose: 2015 VS 2020 VS 2026 | |
| Table 12. Global Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 13. Global Covid-19 Vaccine Revenue Market Share by Purpose (2015-2020) | |
| Table 14. Global Covid-19 Vaccine Forecasted Market Size by Purpose (2021-2026) (US$ Million) | |
| Table 15. Global Covid-19 Vaccine Revenue Market Share by Purpose (2021-2026) | |
| Table 16. Global Covid-19 Vaccine Revenue (US$ Million) by Players (2015-2020) | |
| Table 17. Global Covid-19 Vaccine Revenue Market Share by Players (2015-2020) | |
| Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Vaccine as of 2019) | |
| Table 19. Date of Key Manufacturers Enter into Covid-19 Vaccine Market | |
| Table 20. Global Covid-19 Vaccine Top Players Headquarters and Area Served | |
| Table 21. Covid-19 Vaccine Product Solution and Service | |
| Table 22. Global Covid-19 Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) | |
| Table 23. Mergers & Acquisitions, Expansion Plans | |
| Table 24. Company 1 Basic Information List | |
| Table 25. Company 1 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 26. Company 1 Covid-19 Vaccine Products, Services and Solutions | |
| Table 27. Revenue (Million US$) in Covid-19 Vaccine Business of Company 1 (2015-2020) | |
| Table 28. Company 1 Recent Developments | |
| Table 29. Company 2 Basic Information List | |
| Table 30. Company 2 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 31. Company 2 Covid-19 Vaccine Products, Services and Solutions | |
| Table 32. Revenue (Million US$) in Covid-19 Vaccine Business of Company 2 (2015-2020) | |
| Table 33. Company 2 Recent Developments | |
| Table 34. Company 3 Basic Information List | |
| Table 35. Company 3 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 36. Company 3 Covid-19 Vaccine Products, Services and Solutions | |
| Table 37. Revenue (Million US$) in Covid-19 Vaccine Business of Company 3 (2015-2020) | |
| Table 38. Company 3 Recent Developments | |
| Table 39. Company 4 Basic Information List | |
| Table 40. Company 4 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 41. Company 4 Covid-19 Vaccine Products, Services and Solutions | |
| Table 42. Revenue (Million US$) in Covid-19 Vaccine Business of Company 4 (2015-2020) | |
| Table 43. Company 4 Recent Developments | |
| Table 44. Company 5 Basic Information List | |
| Table 45. Company 5 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 46. Company 5 Covid-19 Vaccine Products, Services and Solutions | |
| Table 47. Revenue (Million US$) in Covid-19 Vaccine Business of Company 5 (2015-2020) | |
| Table 48. Company 5 Recent Developments | |
| Table 49. Company 6 Basic Information List | |
| Table 50. Company 6 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 51. Company 6 Covid-19 Vaccine Products, Services and Solutions | |
| Table 52. Revenue (Million US$) in Covid-19 Vaccine Business of Company 6 (2015-2020) | |
| Table 53. Company 6 Recent Developments | |
| Table 54. Company 7 Basic Information List | |
| Table 55. Company 7 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 56. Company 7 Covid-19 Vaccine Products, Services and Solutions | |
| Table 57. Revenue (Million US$) in Covid-19 Vaccine Business of Company 7 (2015-2020) | |
| Table 58. Company 7 Recent Developments | |
| Table 59. Company 8 Basic Information List | |
| Table 60. Company 8 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 61. Company 8 Covid-19 Vaccine Products, Services and Solutions | |
| Table 62. Revenue (Million US$) in Covid-19 Vaccine Business of Company 8 (2015-2020) | |
| Table 63. Company 8 Recent Developments | |
| Table 64. Company 9 Basic Information List | |
| Table 65. Company 9 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 66. Company 9 Covid-19 Vaccine Products, Services and Solutions | |
| Table 67. Revenue (Million US$) in Covid-19 Vaccine Business of Company 9 (2015-2020) | |
| Table 68. Company 9 Recent Developments | |
| Table 69. Company 10 Basic Information List | |
| Table 70. Company 10 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| èr líng èr líng nián zhì 2026 nián quánqiú Covid-19 yìmiáo hángyè shēndù yánjiū jí fāzhǎn qūshì yùcè bàogào | |
| Table 71. Company 10 Covid-19 Vaccine Products, Services and Solutions | |
| Table 72. Revenue (Million US$) in Covid-19 Vaccine Business of Company 10 (2015-2020) | |
| Table 73. Company 10 Recent Developments | |
| Table 74. Company 11 Basic Information List | |
| Table 75. Company 11 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 76. Company 11 Covid-19 Vaccine Products, Services and Solutions | |
| Table 77. Revenue (Million US$) in Covid-19 Vaccine Business of Company 11 (2015-2020) | |
| Table 78. Company 11 Recent Developments | |
| Table 79. Company 12 Basic Information List | |
| Table 80. Company 12 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 81. Company 12 Covid-19 Vaccine Products, Services and Solutions | |
| Table 82. Revenue (Million US$) in Covid-19 Vaccine Business of Company 12 (2015-2020) | |
| Table 83. Company 12 Recent Developments | |
| Table 84. Company 13 Basic Information List | |
| Table 85. Company 13 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 86. Company 13 Covid-19 Vaccine Products, Services and Solutions | |
| Table 87. Revenue (Million US$) in Covid-19 Vaccine Business of Company 13 (2015-2020) | |
| Table 88. Company 13 Recent Developments | |
| Table 89. Company 14 Basic Information List | |
| Table 90. Company 14 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 91. Company 14 Covid-19 Vaccine Products, Services and Solutions | |
| Table 92. Revenue (Million US$) in Covid-19 Vaccine Business of Company 14 (2015-2020) | |
| Table 93. Company 14 Recent Developments | |
| Table 94. Company 15 Basic Information List | |
| Table 95. Company 15 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 96. Company 15 Covid-19 Vaccine Products, Services and Solutions | |
| Table 97. Revenue (Million US$) in Covid-19 Vaccine Business of Company 15 (2015-2020) | |
| Table 98. Company 15 Recent Developments | |
| Table 99. Company 16 Basic Information List | |
| Table 100. Company 16 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 101. Company 16 Covid-19 Vaccine Products, Services and Solutions | |
| Table 102. Revenue (Million US$) in Covid-19 Vaccine Business of Company 16 (2015-2020) | |
| Table 103. Company 16 Recent Developments | |
| Table 104. Company 17 Basic Information List | |
| Table 105. Company 17 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 106. Company 17 Covid-19 Vaccine Products, Services and Solutions | |
| Table 107. Revenue (Million US$) in Covid-19 Vaccine Business of Company 17 (2015-2020) | |
| Table 108. Company 17 Recent Developments | |
| Table 109. Company 18 Basic Information List | |
| Table 110. Company 18 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 111. Company 18 Covid-19 Vaccine Products, Services and Solutions | |
| Table 112. Revenue (Million US$) in Covid-19 Vaccine Business of Company 18 (2015-2020) | |
| Table 113. Company 18 Recent Developments | |
| Table 114. Company 19 Basic Information List | |
| Table 115. Company 19 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 116. Company 19 Covid-19 Vaccine Products, Services and Solutions | |
| Table 117. Revenue (Million US$) in Covid-19 Vaccine Business of Company 19 (2015-2020) | |
| Table 118. Company 19 Recent Developments | |
| Table 119. Company 3 Basic Information List | |
| Table 120. Company 3 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 121. Company 3 Covid-19 Vaccine Products, Services and Solutions | |
| Table 122. Revenue (Million US$) in Covid-19 Vaccine Business of Company 3 (2015-2020) | |
| Table 123. Company 3 Recent Developments | |
| Table 124. Company 21 Basic Information List | |
| Table 125. Company 21 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 126. Company 21 Covid-19 Vaccine Products, Services and Solutions | |
| Table 127. Revenue (Million US$) in Covid-19 Vaccine Business of Company 21 (2015-2020) | |
| Table 128. Company 21 Recent Developments | |
| Table 129. Company 22 Basic Information List | |
| Table 130. Company 22 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 131. Company 22 Covid-19 Vaccine Products, Services and Solutions | |
| Table 132. Revenue (Million US$) in Covid-19 Vaccine Business of Company 22 (2015-2020) | |
| Table 133. Company 22 Recent Developments | |
| Table 134. Company 23 Basic Information List | |
| Table 135. Company 23 Description, Business Overview and Total Revenue (US$ Million) Generated in 2019 | |
| Table 136. Company 23 Covid-19 Vaccine Products, Services and Solutions | |
| Table 137. Revenue (Million US$) in Covid-19 Vaccine Business of Company 23 (2015-2020) | |
| Table 138. Company 23 Recent Developments | |
| Table 139. Global Covid-19 Vaccine Market Size by Type (2015-2020) (Million US$) | |
| Table 140. North America Covid-19 Vaccine Market Size by Players (2015-2020) (US$ Million) | |
| Table 141. North America Covid-19 Vaccine Market Size Share by Players (2015-2020) | |
| Table 142. North America Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 143. Europe Covid-19 Vaccine Market Size by Players (2015-2020) (US$ Million) | |
| Table 144. Europe Covid-19 Vaccine Market Size Share by Players (2015-2020) | |
| Table 145. Europe Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 146. China Covid-19 Vaccine Market Size by Players (2015-2020) (US$ Million) | |
| Table 147. China Covid-19 Vaccine Market Size Share by Players (2015-2020) (US$ Million) | |
| 2020-2026グローバルCovid-19ワクチン業界の深い研究動向予測レポート | |
| Table 148. China Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 149. Rest of Asia Pacific Covid-19 Vaccine Market Size by Players (2015-2020) (US$ Million) | |
| Table 150. Rest of Asia Pacific Covid-19 Vaccine Market Size Share by Players (2015-2020) (US$ Million) | |
| Table 151. Rest of Asia Pacific Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 152. Latin America Covid-19 Vaccine Market Size by Players (2015-2020) (US$ Million) | |
| Table 153. Latin America Covid-19 Vaccine Market Size Share by Players (2015-2020) (US$ Million) | |
| Table 154. Latin America Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 155. Middle East & Africa Covid-19 Vaccine Market Size by Players (2015-2020) (US$ Million) | |
| Table 156. Middle East & Africa Covid-19 Vaccine Market Size Share by Players (2015-2020) (US$ Million) | |
| Table 157. Middle East & Africa Covid-19 Vaccine Market Size by Purpose (2015-2020) (US$ Million) | |
| Table 158. Market Top Trends | |
| Table 159. Key Drivers: Impact Analysis (2021-2026) | |
| Table 160. Key Challenges | |
| Table 161. Research Programs/Design for This Report | |
| Table 162. Key Data Information from Secondary Sources | |
| Table 163. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Global Covid-19 Vaccine Market Size (US$ Million) Status and Outlook (2015-2026) | |
| Figure 2. Global Covid-19 Vaccine Market Share by Regions: 2020 VS 2026 | |
| Figure 3. North America Covid-19 Vaccine Market Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 4. Europe Covid-19 Vaccine Market Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 5. China Covid-19 Vaccine Market Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 6. Rest of Asia Pacific Covid-19 Vaccine Market Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 7. Latin America Covid-19 Vaccine Market Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 8. Middle East & Africa Covid-19 Vaccine Market Size (US$ Million) and Growth Rate (2015-2026) | |
| Figure 9. Global Covid-19 Vaccine Market Share by Platform in 2020 & 2026 | |
| Figure 10. DNA Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 11. Live Attenuated Virus Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 12. NonReplicating Viral Vecto Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 13. Protein Subunit Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 14. RNA Market Size (US$ Million) YoY Growth (2015-2026) | |
| Figure 15. Global Covid-19 Vaccine Market Size Share by Purpose in 2020 & 2026 | |
| Figure 16. Covid-19 Vaccine Market Size (US$ Million) and Growth Rate in Treatment (2015-2020) | |
| Figure 17. Covid-19 Vaccine Market Size (US$ Million) and Growth Rate in Prevention (2015-2020) | |
| Figure 18. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 | |
| Figure 19. Global Top 5 and Top 10 Players Covid-19 Vaccine Market Share in 2019 | |
| Figure 20. Europe Covid-19 Vaccine Revenue Market Share by Purpose (2015-2020) | |
| Figure 21. China Covid-19 Vaccine Revenue Market Share by Purpose (2015-2020) | |
| Figure 22. Rest of Asia Pacific Covid-19 Vaccine Revenue Market Share by Purpose (2015-2020) | |
| Figure 23. Latin America Covid-19 Vaccine Revenue Market Share by Purpose (2015-2020) | |
| Figure 24. Middle East & Africa Covid-19 Vaccine Revenue Market Share by Purpose (2015-2020) | |
| Figure 25. Porter's Five Forces Analysis | |
| Figure 26. Bottom-up and Top-down Approaches for This Report | |
| Figure 27. Data Triangulation | |
…
如需購買《2020-2026 Global Covid-19 Vaccine Industry In-Depth Research and Trends Forecast Report》，編號：2727296
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號